DCGI
Biological E’s Corbevax gets DCGI nod
On Monday, the Drugs Controller General of India (DCGI) approved Hyderabad-based Biological E's Covid-19 vaccine Corbevax for use in children…
DCGI nod to SII to make COVID vaccine against Omicron for test, analysis
Official sources claimed on Monday that the Drugs Controller General of India (DCGI) has accepted Serum Institute of India's application…
School reopening: Is it the ideal time? Experts discuss
After all the festivities end, it’s about time children go back to school as several states finally open doors from…
Serum Institute seeks permit from DCGI for Covovax
Official sources said the Serum Institute of India applied to the Drugs Controller General of India (DCGI) on Friday for…
DGCI has certified three FDCs comprising cefixime and cefadroxil as reasonable
The Drugs Controller General (India) has approved the three fixed dose combinations (FDCs) cefixime+cloxacillin, cefaxime+cloxacillin+lactobacillus, and cefadroxil+clavulanic acid as reasonable…
DCGI accepts proposal to study mixing of Covid-19 vaccine doses
The Drugs Controller General of India (DCGI) has accepted a proposal that a research be conducted to analyse mixing a…
DCGI receives further data on Zydus Cadila’s Covid-19 vaccine: Report
Ahmedabad-based Zydus Cadila, which has created India's second home-made coronavirus vaccine (Covid-19), has reportedly submitted more data related to the…
Zydus’ Covid vaccine for kids above 12 may come up this week
The drug regulatory body of India will consider emergency use approval for Zydus Cadila’s Covid-19 vaccine this week and the…
Cipla receives DCGI nod for import of Moderna’s Covid-19 vaccine for restricted emergency use in India
India's drug regulator DCGI has granted permission to Mumbai-based pharmaceutical company Cipla to import Moderna's COVID-19 vaccine for restricted emergency use in the country,…
AIIMS Delhi to start screening children today for Covaxin trials
The All India Medical Institute of Medical Sciences (AIIMS) is expected to start screening of children for clinical trials of…